HK51396A - Direct compression cholestyramine tablet and solvent-free coating therefor - Google Patents

Direct compression cholestyramine tablet and solvent-free coating therefor Download PDF

Info

Publication number
HK51396A
HK51396A HK51396A HK51396A HK51396A HK 51396 A HK51396 A HK 51396A HK 51396 A HK51396 A HK 51396A HK 51396 A HK51396 A HK 51396A HK 51396 A HK51396 A HK 51396A
Authority
HK
Hong Kong
Prior art keywords
percent
cholestyramine
tablet
agglomerates
weight
Prior art date
Application number
HK51396A
Other languages
German (de)
English (en)
French (fr)
Inventor
Robert J. Bequette
Bruce A. Bonenberger
Claude E. Gallian
John R. Reckelhoff
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of HK51396A publication Critical patent/HK51396A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
HK51396A 1989-03-16 1996-03-21 Direct compression cholestyramine tablet and solvent-free coating therefor HK51396A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/324,167 US4956182A (en) 1989-03-16 1989-03-16 Direct compression cholestyramine tablet and solvent-free coating therefor

Publications (1)

Publication Number Publication Date
HK51396A true HK51396A (en) 1996-03-29

Family

ID=23262387

Family Applications (1)

Application Number Title Priority Date Filing Date
HK51396A HK51396A (en) 1989-03-16 1996-03-21 Direct compression cholestyramine tablet and solvent-free coating therefor

Country Status (34)

Country Link
US (1) US4956182A (cs)
EP (1) EP0387885B1 (cs)
JP (1) JP2974719B2 (cs)
KR (1) KR0140211B1 (cs)
CN (1) CN1047935C (cs)
AR (1) AR246012A1 (cs)
AT (1) ATE128031T1 (cs)
AU (1) AU617601B2 (cs)
BG (1) BG60501B1 (cs)
CA (1) CA2012300A1 (cs)
CS (1) CS277488B6 (cs)
CY (1) CY1899A (cs)
DD (1) DD292837A5 (cs)
DE (1) DE69022452T2 (cs)
DK (1) DK0387885T3 (cs)
EG (1) EG19669A (cs)
ES (1) ES2078917T3 (cs)
FI (1) FI92464C (cs)
GR (1) GR3017460T3 (cs)
HK (1) HK51396A (cs)
HU (1) HU209958B (cs)
IE (1) IE70591B1 (cs)
IL (1) IL93720A0 (cs)
MY (1) MY109744A (cs)
NO (1) NO176043C (cs)
NZ (1) NZ232864A (cs)
OA (1) OA09198A (cs)
PL (1) PL163301B1 (cs)
PT (1) PT93452B (cs)
RO (1) RO106953B1 (cs)
RU (1) RU2069558C1 (cs)
YU (1) YU52390A (cs)
ZA (1) ZA902001B (cs)
ZW (1) ZW1890A1 (cs)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5372823A (en) * 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
US5262167A (en) * 1990-12-20 1993-11-16 Basf Corporation Edible, non-baked low moisture cholestyramine composition
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
AU700645B2 (en) * 1994-09-22 1999-01-14 N.V. Organon Process of making dosage units by wet granulation
JP4010585B2 (ja) * 1996-10-15 2007-11-21 久光製薬株式会社 陰イオン交換樹脂を含有する錠剤
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
CA2348871C (en) * 1998-11-02 2009-04-14 John G. Devane Multiparticulate modified release composition
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
MXPA02004293A (es) 1999-10-29 2002-10-31 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada..
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
MXPA03003895A (es) 2000-10-30 2003-07-28 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada.
DE60211130T2 (de) * 2001-02-13 2006-11-30 Astrazeneca Ab Neue formulierung mit modifizierter freisetzung
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
KR20040045031A (ko) 2001-09-28 2004-05-31 맥네일-피피씨, 인코포레이티드 상이한 형상의 내부 코어와 외부 셸을 가진 제형
RU2234915C2 (ru) * 2002-06-04 2004-08-27 Дж. Б. Кемикалс энд Фармасьютикалс Лтд. Твердая фармацевтическая композиция для перорального введения и способ ее получения
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
EP1765307B1 (de) * 2004-05-24 2012-11-21 Mepha Schweiz AG Trockenbeschichtungsverfahren
WO2006045512A1 (en) * 2004-10-19 2006-05-04 Krka, Tovarna Zdravil Solid pharmaceutical composition comprising donepezil hydrochloride
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
JP2009507019A (ja) 2005-09-02 2009-02-19 ジェンザイム・コーポレーション リン酸塩を除去する方法およびそれに使用される重合体
CN103027896B (zh) 2005-09-15 2016-01-20 基酶有限公司 胺聚合物的小袋制剂
DE102005060377A1 (de) * 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
US20090252794A1 (en) * 2006-08-09 2009-10-08 Tetsuya Suzuki Tablet
WO2008042222A2 (en) 2006-09-29 2008-04-10 Genzyme Corporation Amide dendrimer compositions
EP2120972A1 (en) 2006-12-14 2009-11-25 Genzyme Corporation Amido-amine polymer compositions
MX356111B (es) 2012-04-18 2018-05-15 SpecGx LLC Composiciones farmaceuticas disuasorias de abuso, de liberacion inmediata.
US10016959B2 (en) 2013-10-25 2018-07-10 Kuraray Co., Ltd. Multilayer film and interlayer film for laminated glass therefrom
ES2963078T3 (es) * 2014-07-03 2024-03-25 SpecGx LLC Formulaciones de liberación inmediata disuasorias del abuso que comprenden polisacáridos no celulósicos
EP3413877B1 (en) * 2016-02-09 2021-04-07 Albireo AB Oral cholestyramine formulation and use thereof
CA3011595C (en) * 2016-02-09 2024-01-02 Albireo Ab Cholestyramine pellets and methods for preparation thereof
CA3112030A1 (en) 2018-09-25 2020-04-02 SpecGx LLC Abuse deterrent immediate release capsule dosage forms
CN114053234A (zh) * 2021-12-29 2022-02-18 江苏省药物研究所有限公司 一种阿卡波糖片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB595444A (en) * 1945-07-09 1947-12-04 Gwilym Lloyd Thomas Improvements in or relating to medicaments, and to the preparation thereof
US3383237A (en) * 1964-01-29 1968-05-14 Richardson Merrell Inc Tablet coating
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
ZA876640B (en) * 1986-09-26 1988-03-08 Warner-Lambert Company Treated lipid regulator
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale

Also Published As

Publication number Publication date
HU901429D0 (en) 1990-06-28
IE900941L (en) 1990-09-16
PT93452B (pt) 1996-12-31
ZW1890A1 (en) 1990-10-31
NO176043B (no) 1994-10-17
ATE128031T1 (de) 1995-10-15
KR0140211B1 (ko) 1998-06-01
NO901183L (no) 1990-09-17
JPH03236326A (ja) 1991-10-22
HUT54489A (en) 1991-03-28
ZA902001B (en) 1990-11-28
AU5136790A (en) 1990-09-20
IE70591B1 (en) 1996-12-11
AR246012A1 (es) 1994-03-30
BG60501B1 (bg) 1995-06-30
KR900013946A (ko) 1990-10-22
JP2974719B2 (ja) 1999-11-10
OA09198A (fr) 1992-06-30
MY109744A (en) 1997-05-31
YU52390A (en) 1991-10-31
PL163301B1 (en) 1994-03-31
CA2012300A1 (en) 1990-09-16
EP0387885A2 (en) 1990-09-19
NO176043C (no) 1995-01-25
CS277488B6 (en) 1993-03-17
PT93452A (pt) 1990-11-07
HU209958B (en) 1994-12-28
FI92464B (fi) 1994-08-15
US4956182A (en) 1990-09-11
FI92464C (fi) 1994-11-25
EG19669A (en) 1995-08-30
EP0387885B1 (en) 1995-09-20
DE69022452T2 (de) 1996-03-14
DD292837A5 (de) 1991-08-14
GR3017460T3 (en) 1995-12-31
CN1047935C (zh) 2000-01-05
ES2078917T3 (es) 1996-01-01
CN1045921A (zh) 1990-10-10
FI901241A0 (fi) 1990-03-13
IL93720A0 (en) 1990-12-23
RO106953B1 (ro) 1993-08-30
NO901183D0 (no) 1990-03-14
RU2069558C1 (ru) 1996-11-27
EP0387885A3 (en) 1992-06-17
CY1899A (en) 1990-03-15
NZ232864A (en) 1992-04-28
AU617601B2 (en) 1991-11-28
DE69022452D1 (de) 1995-10-26
DK0387885T3 (da) 1995-11-06
BG91463A (bg) 1993-12-24

Similar Documents

Publication Publication Date Title
EP0387885B1 (en) Direct compression cholestyramine tablet and solvent-free coating therefor
US5455047A (en) Direct compression cholestyramine tablet and solvent-free coating therefor
US6358526B1 (en) Method of making tablets and tablet compositions produced therefrom
US4900557A (en) Pellet formulation
US20020044969A1 (en) Method for increasing the compressibility of poorly binding powder materials
MXPA02000290A (es) Forma de dosificacion oral de liberacion inmediata rapida.
CA2043864A1 (en) Direct compression cyclophosphamide tablet
EP2496261B1 (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
EP1226818A1 (en) Pharmaceutical dosage forms with enhanced cohesive and compressibility properties
US5635208A (en) Granulation process for producing an acetaminophen and diphenhydramine hydrochloride composition and composition produced by same
US6066336A (en) Cholesterol-lowering tablets
US5985323A (en) Microcrystalline cellulose/alginate wet granulation excipient/binder
US6716453B1 (en) Method for increasing the active loading of compressible composition forms
EA015349B1 (ru) Твёрдая разовая пероральная фармацевтическая дозированная форма саквинавирмезилата и способ её изготовления
JP3681185B2 (ja) 錠剤製造用ニフェジピン固体粒子組成物
JP2006176496A (ja) 固形剤およびその製造方法
SK2182003A3 (sk) Perorálny liečivý prípravok s postupným uvoľňovaním alfuzosin hydrochloridu a spôsob jeho prípravy

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20100314